TY - CHAP M1 - Book, Section TI - Epidemiology of Lung Cancer A1 - Dela Cruz, Charles S. A1 - Tanoue, Lynn T. A1 - Matthay, Richard A. A2 - Grippi, Michael A. A2 - Elias, Jack A. A2 - Fishman, Jay A. A2 - Kotloff, Robert M. A2 - Pack, Allan I. A2 - Senior, Robert M. A2 - Siegel, Mark D. PY - 2015 T2 - Fishman's Pulmonary Diseases and Disorders, 5e AB - Lung cancer is the leading cause of cancer death in the United States and worldwide. Siegel et al.1 estimated a total of 246,210 new lung cancer cases and 163,890 deaths from lung cancer in the United States in 2013.1,2 These statistics reflect data ending in 2009, and likely underestimate the current lung cancer burden. In the United States, more Americans die of lung cancer every year than from prostate, breast, and colon cancer combined.1 Cancer of the lung and bronchus ranked second in cancer incidence in both sexes, with an estimated 118,080 new cases in males (14% of all new cancers) and 110,110 in females (14% of all new cancers).1 The age-adjusted incidence rate of lung cancer was 62 per 100,000 men and women per year in the United States, with the incidence rate much higher in men than in women (75.2 vs. 52.3 per 100,000).3 Lung cancer ranked first in both sexes in the number of estimated deaths yearly1 (87,260 or 28% of all cancer deaths for males and 72,220 or 26% of all cancer deaths for females) (Fig. 109-1). The current 5-year survival rate in the United States for lung cancer is 17%; while this rate has actually increased over the past few decades, it lags behind survival advances in other common malignancies.1 SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accessmedicine.mhmedical.com/content.aspx?aid=1122367052 ER -